All Pharma News
Poseida Presents New Phase 1 Data at AACR 2024

Poseida Presents New Phase 1 Data at AACR 2024
PR NEWSWIRE
08 Apr 2024
Share Share
Poseida Therapeutics to Present at H.C. Wainwright 2nd Cell Therapy Conference

Poseida Therapeutics to Present at H.C. Wainwright 2nd Cell Therapy Conference
PR NEWSWIRE
19 Mar 2024
Share Share
Poseida makes case for safety of Roche-partnered nonviral CAR-T

Poseida makes case for safety of Roche-partnered nonviral CAR-T
Gabrielle Masson FIERCE BIOTECH
10 Dec 2023
Share Share
Poseida promotes cell therapy president to CEO; Neumora appoints R&D chief

Poseida promotes cell therapy president to CEO; Neumora appoints R&D chief
Alex Hoffman ENDPTS
13 Oct 2023
Share Share
Poseida Announces FDA Clearance of Investigational NDA for P-CD19CD20-ALLO1

Poseida Announces FDA Clearance of Investigational NDA for P-CD19CD20-ALLO1
PR NEWSWIRE
05 Jul 2023
Share Share
Poseida Presents Preclinical Data Across its Gene Therapy Programs

Poseida Presents Preclinical Data Across its Gene Therapy Programs
PR NEWSWIRE
18 May 2023
Share Share
Poseida Therapeutics Provides Updates and Financial Results for the 1Q of 2023

Poseida Therapeutics Provides Updates and Financial Results for the 1Q of 2023
PR NEWSWIRE
09 May 2023
Share Share
Poseida Therapeutics Names Kristin Yarema President, Cell Therapy

Poseida Therapeutics Names Kristin Yarema President, Cell Therapy
CONTRACT PHARMA
11 Apr 2023
Share Share
Poseida Provides Financial Results for the Fourth Quarter and Full Year 2022

Poseida Provides Financial Results for the Fourth Quarter and Full Year 2022
PR NEWSWIRE
09 Mar 2023
Share Share
Poseida Appoints Five New Members to Its Gene Therapy Scientific Advisory Board

Poseida Appoints Five New Members to Its Gene Therapy Scientific Advisory Board
PR NEWSWIRE
01 Mar 2023
Share Share